Use of psychotropic medications during pregnancy: perception of teratogenic risk among physicians in two Latin American countries

Bibliographic Details
Main Author: Cantilino,Amaury
Publication Date: 2014
Other Authors: Lorenzo,Laura, Paula,Juliane dos A. de, Einarson,Adrienne
Format: Article
Language: eng
Source: Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
Download full: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462014000200106
Summary: Objective: Pregnant women and their health care professionals commonly believe that use of medications during pregnancy may be harmful to the unborn fetus. The objective of this study was to evaluate the risk perception of psychotropic drug use in pregnancy among physicians in different medical specialties. Method: This was a convenience survey conducted at outpatient clinics in the cities of Recife, Brazil, and La Plata, Bahía Blanca, and Buenos Aires, Argentina. Physicians who agreed to participate were asked to rate their perception of teratogenic risk among different classes of drugs, which included antidepressants, antipsychotics, anticonvulsants, and benzodiazepines. Results: Two hundred and thirty-eight physicians completed the survey (response rate, 98%). These included psychiatrists, obstetricians, neurologists, cardiologists, gastroenterologists, and general practitioners. Among different specialties, a minority of psychiatrists perceived psychotropic drugs to be highly teratogenic (antidepressants, 12.5%; antipsychotics, 15%; benzodiazepines, 25%) as compared with other specialties (p < 0.003 for each drug class). There was no difference in perceived risk of antiepileptic drugs among specialties, including psychiatrists. Conclusion: The risk associated with use of psychotropic drugs in pregnancy was overestimated by physicians of all medical specialties, except psychiatry. All physicians should be aware of the safety/risk of psychotropic agents in pregnancy, as they may be required to give advice and/or prescribe these drugs to pregnant women.
id ABP-1_ab83c5aa06bcbd373eebb5ca377845d9
oai_identifier_str oai:scielo:S1516-44462014000200106
network_acronym_str ABP-1
network_name_str Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
repository_id_str
spelling Use of psychotropic medications during pregnancy: perception of teratogenic risk among physicians in two Latin American countriesPerceptionpsychotropic drugspregnancyteratogens Objective: Pregnant women and their health care professionals commonly believe that use of medications during pregnancy may be harmful to the unborn fetus. The objective of this study was to evaluate the risk perception of psychotropic drug use in pregnancy among physicians in different medical specialties. Method: This was a convenience survey conducted at outpatient clinics in the cities of Recife, Brazil, and La Plata, Bahía Blanca, and Buenos Aires, Argentina. Physicians who agreed to participate were asked to rate their perception of teratogenic risk among different classes of drugs, which included antidepressants, antipsychotics, anticonvulsants, and benzodiazepines. Results: Two hundred and thirty-eight physicians completed the survey (response rate, 98%). These included psychiatrists, obstetricians, neurologists, cardiologists, gastroenterologists, and general practitioners. Among different specialties, a minority of psychiatrists perceived psychotropic drugs to be highly teratogenic (antidepressants, 12.5%; antipsychotics, 15%; benzodiazepines, 25%) as compared with other specialties (p < 0.003 for each drug class). There was no difference in perceived risk of antiepileptic drugs among specialties, including psychiatrists. Conclusion: The risk associated with use of psychotropic drugs in pregnancy was overestimated by physicians of all medical specialties, except psychiatry. All physicians should be aware of the safety/risk of psychotropic agents in pregnancy, as they may be required to give advice and/or prescribe these drugs to pregnant women. Associação Brasileira de Psiquiatria2014-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462014000200106Brazilian Journal of Psychiatry v.36 n.2 2014reponame:Brazilian Journal of Psychiatry (São Paulo. 1999. Online)instname:Associação Brasileira de Psiquiatria (ABP)instacron:ABP10.1590/1516-4446-2013-1221info:eu-repo/semantics/openAccessCantilino,AmauryLorenzo,LauraPaula,Juliane dos A. deEinarson,Adrienneeng2014-06-27T00:00:00Zoai:scielo:S1516-44462014000200106Revistahttp://www.bjp.org.br/ahead_of_print.asphttps://old.scielo.br/oai/scielo-oai.php||rbp@abpbrasil.org.br1809-452X1516-4446opendoar:2014-06-27T00:00Brazilian Journal of Psychiatry (São Paulo. 1999. Online) - Associação Brasileira de Psiquiatria (ABP)false
dc.title.none.fl_str_mv Use of psychotropic medications during pregnancy: perception of teratogenic risk among physicians in two Latin American countries
title Use of psychotropic medications during pregnancy: perception of teratogenic risk among physicians in two Latin American countries
spellingShingle Use of psychotropic medications during pregnancy: perception of teratogenic risk among physicians in two Latin American countries
Cantilino,Amaury
Perception
psychotropic drugs
pregnancy
teratogens
title_short Use of psychotropic medications during pregnancy: perception of teratogenic risk among physicians in two Latin American countries
title_full Use of psychotropic medications during pregnancy: perception of teratogenic risk among physicians in two Latin American countries
title_fullStr Use of psychotropic medications during pregnancy: perception of teratogenic risk among physicians in two Latin American countries
title_full_unstemmed Use of psychotropic medications during pregnancy: perception of teratogenic risk among physicians in two Latin American countries
title_sort Use of psychotropic medications during pregnancy: perception of teratogenic risk among physicians in two Latin American countries
author Cantilino,Amaury
author_facet Cantilino,Amaury
Lorenzo,Laura
Paula,Juliane dos A. de
Einarson,Adrienne
author_role author
author2 Lorenzo,Laura
Paula,Juliane dos A. de
Einarson,Adrienne
author2_role author
author
author
dc.contributor.author.fl_str_mv Cantilino,Amaury
Lorenzo,Laura
Paula,Juliane dos A. de
Einarson,Adrienne
dc.subject.por.fl_str_mv Perception
psychotropic drugs
pregnancy
teratogens
topic Perception
psychotropic drugs
pregnancy
teratogens
description Objective: Pregnant women and their health care professionals commonly believe that use of medications during pregnancy may be harmful to the unborn fetus. The objective of this study was to evaluate the risk perception of psychotropic drug use in pregnancy among physicians in different medical specialties. Method: This was a convenience survey conducted at outpatient clinics in the cities of Recife, Brazil, and La Plata, Bahía Blanca, and Buenos Aires, Argentina. Physicians who agreed to participate were asked to rate their perception of teratogenic risk among different classes of drugs, which included antidepressants, antipsychotics, anticonvulsants, and benzodiazepines. Results: Two hundred and thirty-eight physicians completed the survey (response rate, 98%). These included psychiatrists, obstetricians, neurologists, cardiologists, gastroenterologists, and general practitioners. Among different specialties, a minority of psychiatrists perceived psychotropic drugs to be highly teratogenic (antidepressants, 12.5%; antipsychotics, 15%; benzodiazepines, 25%) as compared with other specialties (p < 0.003 for each drug class). There was no difference in perceived risk of antiepileptic drugs among specialties, including psychiatrists. Conclusion: The risk associated with use of psychotropic drugs in pregnancy was overestimated by physicians of all medical specialties, except psychiatry. All physicians should be aware of the safety/risk of psychotropic agents in pregnancy, as they may be required to give advice and/or prescribe these drugs to pregnant women.
publishDate 2014
dc.date.none.fl_str_mv 2014-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462014000200106
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462014000200106
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1516-4446-2013-1221
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Psiquiatria
publisher.none.fl_str_mv Associação Brasileira de Psiquiatria
dc.source.none.fl_str_mv Brazilian Journal of Psychiatry v.36 n.2 2014
reponame:Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
instname:Associação Brasileira de Psiquiatria (ABP)
instacron:ABP
instname_str Associação Brasileira de Psiquiatria (ABP)
instacron_str ABP
institution ABP
reponame_str Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
collection Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
repository.name.fl_str_mv Brazilian Journal of Psychiatry (São Paulo. 1999. Online) - Associação Brasileira de Psiquiatria (ABP)
repository.mail.fl_str_mv ||rbp@abpbrasil.org.br
_version_ 1754212556470222848